| answer text |
<p>The United Kingdom will leave the European Union on 31 October, with or without
a deal. The Government would prefer the UK to leave the EU with a deal and, in the
event that the UK leaves the EU with a new deal, the Department’s assessment is that
access to medicines and medical devices will not change for industry or the National
Health Service.</p><p>While the Prime Minister is confident that he can strike a new
arrangement with the EU, it is vital that we prepare for a ‘no deal’ outcome. Therefore,
as a responsible Government, we continue to take steps to ensure the supply of medicines
and medical products is uninterrupted in a ‘no deal’ scenario.</p><p>On 26 June, we
wrote to suppliers of medicines to the UK from or via the EU or European Economic
Area setting out our continuing multi-layered approach to ensure the continuity of
supply of all medicines and medical products in a potential ‘no deal’ exit scenario
on 31 October.</p><p>Further details can be found at the following link:</p><p><a
href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans"
target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>Ahead
of 31 October, all necessary funding will be made available to support our ‘no deal’
preparations. On 1 August, Her Majesty’s Treasury announced an additional £434 million
made available to help ensure continuity of supply of vital medicines and medical
products, including through freight capacity, warehousing and stockpiling.</p><p>We
are confident that the Department is doing everything appropriate to prepare for a
possible ‘no deal’ EU exit on 31 October. We are working with our partners, including
suppliers, freight companies and the health and social care system and our plans should
ensure the supply of medicines and medical products remains uninterrupted.</p>
|
|
